1
van der Valk, M.E., Mangen, M. J., Leenders, M, Dijkstra, G., van Bodegraven, A.A., Fidder, H. H., de Jong, D.J., Pierik, M., van der Woude, C.J., Romberg-Camps, M., Clemens, C.H., Jansen, J., Mahmmod, N., van de Meeberg, P.C., van der Meulen-Jong, A.E., Ponsioen, C. Y., Bolwerk, C. J., Vermeijden, J. R., Siersema, P.D., Van Oijen, MG, Oldenburg, B.
Veröffentlicht in: van der Valk , M E , Mangen , M J , Leenders , M , Dijkstra , G , van Bodegraven , A A , Fidder , H H , de Jong , D J , Pierik , M , van der Woude , C J , Romberg-Camps , M , Clemens , C H , Jansen , J , Mahmmod , N , van de Meeberg , P C , van der Meulen-Jong , A E , Ponsioen , C Y , Bolwerk , C J , Vermeijden , J R , Siersema , P D , Van Oijen , MG & Oldenburg , B 2014 , ' Risk factors of work disability in patients with inflammatory bowel disease - A Dutch nationwide web-based survey: Work disability in inflammatory bowel disease. ' , Journal of Crohn's & Colitis , vol. 8 , no. 7 , pp. 590-597 . https://doi.org/10.1016/j.crohns.2013.11.019;
2014
Veröffentlicht in: van der Valk , M E , Mangen , M J , Leenders , M , Dijkstra , G , van Bodegraven , A A , Fidder , H H , de Jong , D J , Pierik , M , van der Woude , C J , Romberg-Camps , M , Clemens , C H , Jansen , J , Mahmmod , N , van de Meeberg , P C , van der Meulen-Jong , A E , Ponsioen , C Y , Bolwerk , C J , Vermeijden , J R , Siersema , P D , Van Oijen , MG & Oldenburg , B 2014 , ' Risk factors of work disability in patients with inflammatory bowel disease - A Dutch nationwide web-based survey: Work disability in inflammatory bowel disease. ' , Journal of Crohn's & Colitis , vol. 8 , no. 7 , pp. 590-597 . https://doi.org/10.1016/j.crohns.2013.11.019;
2014
2
Weersma, R.L.S., Stokkers, P.C., van Bodegraven, A.A., Hogezand, R.J.P., Verspaget, H.W., Jong, D., van der Woude, C.J., Oldenburg, B., Linskens, R.K., Festen, E.A., van der Steege, G., Hommes, D.W., Crusius, J.B.A., Wijmenga, C., Nolte, I., Dijkstra, G.
Veröffentlicht in: Weersma , R L S , Stokkers , P C , van Bodegraven , A A , Hogezand , R J P , Verspaget , H W , Jong , D , van der Woude , C J , Oldenburg , B , Linskens , R K , Festen , E A , van der Steege , G , Hommes , D W , Crusius , J B A , Wijmenga , C , Nolte , I & Dijkstra , G 2009 , ' Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort ' , Gut , vol. 58 , no. 3 , pp. 388-395 . https://doi.org/10.1136/gut.2007.144865;
2009
Veröffentlicht in: Weersma , R L S , Stokkers , P C , van Bodegraven , A A , Hogezand , R J P , Verspaget , H W , Jong , D , van der Woude , C J , Oldenburg , B , Linskens , R K , Festen , E A , van der Steege , G , Hommes , D W , Crusius , J B A , Wijmenga , C , Nolte , I & Dijkstra , G 2009 , ' Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort ' , Gut , vol. 58 , no. 3 , pp. 388-395 . https://doi.org/10.1136/gut.2007.144865;
2009
3
Biemans, V.B.C., Sleutjes, J.A.M., de Vries, A.C., Bodelier, A.G.L., Dijkstra, G., Oldenburg, B., Lowenberg, M., van Bodegraven, A.A., van der Meulen-de Jong, A.E., de Boer, N.K.H., Srivastava, N., West, R.L., Romkens, T.E.H., Horje, C.H.T.S., Jansen, J.M., van der Woude, C.J., Hoekstra, J., Weersma, R.K., van Schaik, F.D.M., Hoentjen, F., Pierik, M.J.
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020